GlassScriptPhysician profile
Nazish Chaudhry
NPI 1205483773
$654.89
in general payments reported to CMS, 2019-2025
11 companies · $65.78 in 2025
The $65.78 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $135 · 2023: $255 · 2024: $199 · 2025: $65.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $123.50 | 2021 | |
| Lilly USA, LLC | $121.85 | 2024 | Mounjaro |
| Medtronic, INC. | $119.62 | 2023 | Sonicision |
| Abbvie INC. | $113.72 | 2023 | Vraylar |
| Exact Sciences Corporation | $48.21 | 2025 | Cologuard Collection Kit |
| Dynavax Technologies Corporation | $34.26 | 2024 | Heplisav-B |
| Novo Nordisk INC | $24.87 | 2024 | Ozempic, Rybelsus |
| Edwards Lifesciences Corporation | $21.41 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Astrazeneca Pharmaceuticals LP | $18.29 | 2024 | Farxiga |
| Glaxosmithkline, LLC. | $17.57 | 2025 | Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $11.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nazish Chaudhry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.